David Roblin, Founder of Relation Therapeutics

David Roblin is the founder of Relation Therapeutics. Relation Therapeutics has raised $80M, latest Seed $25M (2024). Biotech · London, UK.

About David Roblin

David Roblin is the founder of Relation Therapeutics. Relation Therapeutics operates in Biotech and is based in London, UK. Relation Therapeutics has raised $80M, latest Seed $25M (2024). Backers on record include James Hardiman, Matt Ocko, DCVC.

David Roblin at a glance

Company
Relation Therapeutics
Industry
Biotech
Location
London, UK
Total raised
$80M
Investors on record
James Hardiman, Matt Ocko, DCVC

Frequently asked about David Roblin

Who is David Roblin?
David Roblin is the founder of Relation Therapeutics. Full profile, funding history and background on StartupFundraising.com.
What company did David Roblin found?
David Roblin founded Relation Therapeutics, a Biotech company based in London, UK.
How do I contact David Roblin?
Verified contact routes including LinkedIn, background and funding history for David Roblin are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in London — who backed them, at what stage, and how much they raised.

Relation Therapeutics funding profile (1)

More Biotech founders (40)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library